Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.
about
Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartanContribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearanceA pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.Contribution of tumoral and host solute carriers to clinical drug response.Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric LiverAssociation of CYP2C9*2 with bosentan-induced liver injury.Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapyPharmacogenetics of drug transporters in the enterohepatic circulation.Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond.Organic anion-transporting polypeptides: a novel approach for cancer therapy.Transporter-mediated drug-drug interactions with oral antidiabetic drugs.Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development.Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.Recessive inheritance of population-specific intronic LINE-1 insertion causes a rotor syndrome phenotype.Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjectsTransport characteristics and transporter-based drug-drug interactions of TM-25659, a novel TAZ modulator.The influence of oral antidiabetic drugs on cellular drug uptake mediated by hepatic OATP family members.Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population.Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions.
P2860
Q28535089-9F00676D-95C6-46B7-87FB-BC085FE29018Q35375045-6C84210B-A036-4060-853D-4EB3D95B819AQ35917726-50F77C77-D4A6-44C9-B5D6-CA7540E18CE6Q35946876-B736AFA3-151A-4BB2-9A96-DC3E59EA4714Q36036384-A0D5A242-E81E-4EBE-8E36-CDB0C0A89CF6Q36824621-2F4B28FB-7B66-4CC9-AC35-32FBC1C39188Q37062634-4C02E2F5-DDE8-4DB2-A681-B0E72D982883Q37325319-3004A536-2D2D-4515-B866-F6EECE2316ADQ37735146-D6FE2EDA-CDDC-457F-80B6-1B47AC5E4B2BQ37880875-388BE1E3-8804-4F11-AE4D-6F594149429AQ38075057-908BB0CC-3C10-4295-A4C2-DF652B404E48Q38132411-FE7F526D-5E4C-4569-9D18-71F26EF3BFFDQ38168993-6A07AA02-E7FE-4AE0-8257-7A2DE499C55CQ38685293-6C0A0453-2E25-4DBE-84A3-567D60A7E1B7Q38853020-099E77D2-A0CC-43A7-B9E6-54A6B006BCA9Q39015474-252DC3CC-FB05-46BF-A0A5-84EFDEDAAF67Q41642419-958B4844-A440-4743-B049-B99C70BFADB5Q41647064-679FC704-98DB-4EA2-9649-68579EDCE749Q42178200-73AD1613-8EAE-4B30-A99F-1C5C01F7A13CQ42291683-EAB429D6-D699-46FD-A3D6-9EEAE9763FA7Q42450098-1901998A-65EC-497B-9A97-C16BEFA13593Q42714483-9D681027-2089-49C7-AF7D-EBFF7AF27CA6Q47113473-67723A51-CE84-42BC-964F-E235D6538B83Q55046512-EBE5DCAD-E6FE-4F99-946A-ECD969383DE8
P2860
Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of novel functi ...... ment of substrate specificity.
@ast
Identification of novel functi ...... ment of substrate specificity.
@en
Identification of novel functi ...... ment of substrate specificity.
@nl
type
label
Identification of novel functi ...... ment of substrate specificity.
@ast
Identification of novel functi ...... ment of substrate specificity.
@en
Identification of novel functi ...... ment of substrate specificity.
@nl
prefLabel
Identification of novel functi ...... ment of substrate specificity.
@ast
Identification of novel functi ...... ment of substrate specificity.
@en
Identification of novel functi ...... ment of substrate specificity.
@nl
P2093
P2860
P1476
Identification of novel functi ...... ment of substrate specificity.
@en
P2093
Atsuko Suzuki
Brenda F Leake
Henriette E Meyer zu Schwabedissen
Kenji Mizuguchi
Richard B Kim
Richard H Ho
Rommel G Tirona
Ute I Schwarz
Younes Mokrab
P2860
P304
P356
10.1097/FPC.0B013E328342F5B1
P577
2011-03-01T00:00:00Z